期刊文献+

补肾健骨方治疗慢性肾脏病-矿物质和骨异常35例临床观察 被引量:7

Bushen Jiangu Decoction in the Treatment of Mineral and Bone Disorder of Chronic Kidney disease: Clinical Observation of 35 Cases
下载PDF
导出
摘要 目的:观察补肾健骨方治疗慢性肾脏病-矿物质和骨异常(CKD-MBD)的临床疗效。方法:将符合纳入标准的70例患者按随机数字表法分为治疗组、对照组,35例。对照组给予常规治疗,治疗组于常规治疗基础上加服补肾健骨方,疗程4周。观察两组患者的总疗效及治疗前后血清肌酐(Scr)、尿素氮(BUN)、尿酸(UA)、内生肌酐清除率(CCr)、Ca、P、全段甲状旁腺激素(i PTH)的变化;结果:治疗组有效率为82.9%,优于对照组的65.7%(P<0.05);治疗后治疗组BUN水平低于对照组(P<0.05),两组患者Scr、UA、Ca水平比较差异无统计学意义(P>0.05);两组患者血清P、i PTH水平低于治疗前(P<0.05,P<0.01),治疗组优于对照组(P<0.05)。结论:补肾健骨方有助于缓解CKD-MBD患者的临床症状,并在降低尿素氮、血磷及甲状旁腺激素水平、调节钙磷代谢方面具有一定的作用。 Objective: To observe the effect of Bushen Jiangu decoction in the treatment of mineral and bone disorder chronic kidney disease of( CKD- MBD). Methods: A total of 70 patients who met the inclusion criteria were randomly divided into a treatment group and a control group,with 35 cases in each group. The control group was given conventional treatment,and the treatment group was based on the routine treatment plus orally taking Bushen Jiangu decoction,with 4 weeks as a course of treatment. Observe the total effect in two groups according to seram creatinine( Scr),blood urea nitrogen( BUN),uric acid( UA),creatinine clearance rate( CCr),Ca,P,intact parathyroid hormone( i PTH) changes before and after treatment. Results: The effective rate in the treatment group was 82. 9%,which was better than 65. 7% in the control group( P〈0. 05); after treatment,BUN in the treatment group was lower than that in the control group( P〈0. 05),and the two groups had no statistical significance according to Scr,UA,Ca( P〈0. 05); the serum P,i PTH levels in two groups were lower than those before treatment( P〈0. 05,P〈0. 01),and the treatment group was superior to the control group( P〈0. 05). Conclusion: Bushen Jiangu decoction can relieve the clinical symptoms of patients with CKD- MBD,and it plays a role in reducing blood urea nitrogen,serum phosphorus and parathyroid hormone levels,regulating calcium and phosphorus metabolism.
出处 《中医药信息》 2015年第6期77-79,共3页 Information on Traditional Chinese Medicine
基金 黑龙江省教育厅科学技术研究项目(No.12541771)
关键词 补肾健骨方 慢性肾脏病 骨代谢异常 甲状旁腺激素 Bushen Jiangu decoction Chronic kidney disease Abnormality of bone metabolism Parathyroid hormone
  • 相关文献

参考文献3

二级参考文献12

  • 1National Kidney Foundation. KDOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease[ J]. Am J Kidney Dis,2003,42 ( suppl 3 ) : S1 - S202.
  • 2KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) [ J]. Kidney International, 2009,76 ( Suppl 113 ), S1 - S2.
  • 3Vassalotti JA, Uribarri J, Chen SC, et al. Trends in mineral metabo- lism: Kidney Early Evaluation Program (KEEP) and the National Health and Nutrition Examination Survey (NHANES) 1999-2004[J]. Am J Kidney Dis,2008,51 :S56 -S68.
  • 4Regidor DL, Kovesdy CP, Mehrotra R, et al. Serum alkaline phos- phatase predicts mortality among maintenance hemodialysis pa- tients[ J]. J Am Soc Nephrol,2008 ,19 :2193 - 2203.
  • 5Hollis BW. Assessment of vitamin D status and definition of a nor- real circulating range of 25-hydroxyvitamin D [ J]. Curr Opin En- docrinol Diabetes Obes,2008,15 ( 6 ) :489 - 494.
  • 6Tentori F, Blayney M J, Albert JM, et al. Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS) [ J]. Am J Kidney Dis,2008,52:519 -530.
  • 7Ketteler M, Brandenburg V, Jahnen-Dechent W, et al. Do not be misguided by guidelines:the calcium x phosphate product can be a Trojan horse [ J ]. Nephrol Dial Transplant,2005,20:673 - 677.
  • 8Dhingra R, Sullivan LM, Fox CS, et al. Relations of serum phos- phorus and calcium Revels to the incidence of cardiovascular dis- ease in the community [ J 1. Arch lnteru Med, 2007,167 : 879 - 885.
  • 9Barreto FC, Barreto DV, Moyses RM,et al. K/DOQI-recommended intact PTH levels do not prevent low-turnover bone disease in he- modialysis patients[ J]. Kidney Int,2008,73:771 - 777.
  • 10Zhang QL, Rothenbacher D. Prevalence of chronic kidney, disease in population-based studies : systematic review [ J ]. BMC Public Health ,2008,8 : 117.

共引文献59

同被引文献90

引证文献7

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部